Transfusion-dependent anemia: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A condition requiring regular blood transfusions}} | |||
{{Use dmy dates|date=October 2023}} | |||
'''Transfusion-dependent anemia''' is a type of anemia that necessitates regular blood transfusions to manage the condition. This form of anemia is often associated with chronic diseases or genetic disorders that impair the body's ability to produce healthy red blood cells. | |||
Transfusion-dependent anemia can | ==Causes== | ||
Transfusion-dependent anemia can result from various underlying conditions, including: | |||
* [[Thalassemia]]: A genetic disorder that affects hemoglobin production. | |||
* [[Sickle cell disease]]: A hereditary disease that causes red blood cells to become misshapen and break down. | |||
* [[Thalassemia]] | * [[Myelodysplastic syndromes]]: A group of disorders caused by poorly formed or dysfunctional blood cells. | ||
* | * [[Aplastic anemia]]: A condition where the bone marrow fails to produce sufficient blood cells. | ||
* [[ | |||
* [[ | |||
== | ==Management== | ||
The primary treatment for transfusion-dependent anemia is regular blood transfusions. These transfusions help maintain adequate hemoglobin levels and alleviate symptoms such as fatigue and weakness. However, frequent transfusions can lead to iron overload, necessitating additional treatments. | |||
===Iron Chelation Therapy=== | |||
To manage iron overload, patients may require iron chelation therapy. Common chelating agents include: | |||
* [[ | * '''[[Deferoxamine]]''': Administered via injection, it binds to excess iron, allowing it to be excreted from the body. | ||
[[File:Deferoxamine-3D-vdW.png|thumb|right|3D model of Deferoxamine]] | |||
* '''[[Deferiprone]]''': An oral medication that also binds to iron, facilitating its removal. | |||
[[File:Deferiprone-Iron_complex.png|thumb|right|Deferiprone-Iron complex]] | |||
==Complications== | |||
Patients with transfusion-dependent anemia are at risk of several complications, including: | |||
* [[Iron overload]]: Excess iron from repeated transfusions can damage organs such as the heart and liver. | |||
* [[Infections]]: Increased risk due to frequent blood transfusions. | |||
* [[Alloimmunization]]: Development of antibodies against transfused blood cells, complicating future transfusions. | |||
==Prognosis== | |||
The prognosis for individuals with transfusion-dependent anemia varies depending on the underlying cause and the effectiveness of treatment. With proper management, many patients can maintain a good quality of life. | |||
==Related pages== | |||
* [[Anemia]] | * [[Anemia]] | ||
* [[Blood transfusion]] | * [[Blood transfusion]] | ||
* [[Iron | * [[Iron overload]] | ||
==References== | |||
{{Reflist}} | |||
[[File:Ics-codablock-blood-bag sample.jpg|thumb|right|A blood bag used for transfusions]] | |||
[[Category:Anemia]] | [[Category:Anemia]] | ||
[[Category:Blood disorders]] | [[Category:Blood disorders]] | ||
Revision as of 23:59, 9 February 2025
A condition requiring regular blood transfusions
Transfusion-dependent anemia is a type of anemia that necessitates regular blood transfusions to manage the condition. This form of anemia is often associated with chronic diseases or genetic disorders that impair the body's ability to produce healthy red blood cells.
Causes
Transfusion-dependent anemia can result from various underlying conditions, including:
- Thalassemia: A genetic disorder that affects hemoglobin production.
- Sickle cell disease: A hereditary disease that causes red blood cells to become misshapen and break down.
- Myelodysplastic syndromes: A group of disorders caused by poorly formed or dysfunctional blood cells.
- Aplastic anemia: A condition where the bone marrow fails to produce sufficient blood cells.
Management
The primary treatment for transfusion-dependent anemia is regular blood transfusions. These transfusions help maintain adequate hemoglobin levels and alleviate symptoms such as fatigue and weakness. However, frequent transfusions can lead to iron overload, necessitating additional treatments.
Iron Chelation Therapy
To manage iron overload, patients may require iron chelation therapy. Common chelating agents include:
- Deferoxamine: Administered via injection, it binds to excess iron, allowing it to be excreted from the body.

- Deferiprone: An oral medication that also binds to iron, facilitating its removal.

Complications
Patients with transfusion-dependent anemia are at risk of several complications, including:
- Iron overload: Excess iron from repeated transfusions can damage organs such as the heart and liver.
- Infections: Increased risk due to frequent blood transfusions.
- Alloimmunization: Development of antibodies against transfused blood cells, complicating future transfusions.
Prognosis
The prognosis for individuals with transfusion-dependent anemia varies depending on the underlying cause and the effectiveness of treatment. With proper management, many patients can maintain a good quality of life.
Related pages
References
<references group="" responsive="1"></references>
